If this is the first time you are viewing this file, please choose 'Save As' from the 'File' menu
and resave this file as an Excel file type. This will greatly speed up future viewings of this file.
Short-Term Individual Animal Non Neoplastic Diagnosis
Study Information:
Chemical Name: | Trimethylolpropane triacrylate |
CASRN: | ="15625-89-5" |
Study Number: | C88133 |
Exposure Route: | SKIN APPLICATION |
TDMS Number: | 8813301 |
Sex: | Male |
Strain and Species: | F 344/N Rats |
Male Individual Animal Non Neoplastic Diagnoses
System |
Organ |
Site |
Treatment Group |
Number Examined |
Cage Number |
Animal Number |
Days on Study |
Lesion Found |
Lesion Name |
Lesion Qualifier |
Removal Reason |
Integumentary System |
Skin |
Dermis, SOA |
12.5 MG/KG |
5 |
10 |
10 |
17 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
12.5 MG/KG |
5 |
6 |
6 |
17 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
12.5 MG/KG |
5 |
7 |
7 |
17 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
12.5 MG/KG |
5 |
8 |
8 |
17 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
12.5 MG/KG |
5 |
9 |
9 |
17 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
25 MG/KG |
5 |
11 |
11 |
17 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
25 MG/KG |
5 |
12 |
12 |
17 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
25 MG/KG |
5 |
13 |
13 |
17 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
25 MG/KG |
5 |
14 |
14 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
25 MG/KG |
5 |
15 |
15 |
17 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
50 MG/KG |
5 |
16 |
16 |
17 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
50 MG/KG |
5 |
17 |
17 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
50 MG/KG |
5 |
18 |
18 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
50 MG/KG |
5 |
19 |
19 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
50 MG/KG |
5 |
20 |
20 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
100 MG/KG |
5 |
21 |
21 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
100 MG/KG |
5 |
22 |
22 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
100 MG/KG |
5 |
23 |
23 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
100 MG/KG |
5 |
24 |
24 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
100 MG/KG |
5 |
25 |
25 |
17 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
200 MG/KG |
5 |
26 |
26 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
200 MG/KG |
5 |
27 |
27 |
17 |
1 |
Inflammation |
Marked, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
200 MG/KG |
5 |
28 |
28 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
200 MG/KG |
5 |
29 |
29 |
17 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
200 MG/KG |
5 |
30 |
30 |
17 |
1 |
Inflammation |
Marked, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
6 |
6 |
17 |
1 |
Degeneration |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
7 |
7 |
17 |
1 |
Degeneration |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
8 |
8 |
17 |
1 |
Degeneration |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
9 |
9 |
17 |
1 |
Degeneration |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
11 |
11 |
17 |
1 |
Degeneration |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
12 |
12 |
17 |
1 |
Degeneration |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
14 |
14 |
17 |
1 |
Degeneration |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
15 |
15 |
17 |
1 |
Degeneration |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
16 |
16 |
17 |
1 |
Degeneration |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
17 |
17 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
18 |
18 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
19 |
19 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
20 |
20 |
17 |
1 |
Degeneration |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
21 |
21 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
22 |
22 |
17 |
1 |
Degeneration |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
23 |
23 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
24 |
24 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
25 |
25 |
17 |
1 |
Degeneration |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
26 |
26 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
27 |
27 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
28 |
28 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
29 |
29 |
17 |
1 |
Degeneration |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
30 |
30 |
17 |
1 |
Degeneration |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
10 |
10 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
6 |
6 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
7 |
7 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
8 |
8 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
9 |
9 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
11 |
11 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
12 |
12 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
13 |
13 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
14 |
14 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
15 |
15 |
17 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
16 |
16 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
17 |
17 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
18 |
18 |
17 |
1 |
Hyperkeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
19 |
19 |
17 |
1 |
Hyperkeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
20 |
20 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
21 |
21 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
22 |
22 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
23 |
23 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
24 |
24 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
25 |
25 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
26 |
26 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
27 |
27 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
28 |
28 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
29 |
29 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
30 |
30 |
17 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
10 |
10 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
6 |
6 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
7 |
7 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
8 |
8 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
9 |
9 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
11 |
11 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
12 |
12 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
13 |
13 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
14 |
14 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
15 |
15 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
16 |
16 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
17 |
17 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
18 |
18 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
19 |
19 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
20 |
20 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
21 |
21 |
17 |
1 |
Hyperplasia |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
22 |
22 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
23 |
23 |
17 |
1 |
Hyperplasia |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
24 |
24 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
25 |
25 |
17 |
1 |
Hyperplasia |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
26 |
26 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
27 |
27 |
17 |
1 |
Hyperplasia |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
28 |
28 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
29 |
29 |
17 |
1 |
Hyperplasia |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
30 |
30 |
17 |
1 |
Hyperplasia |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
6 |
6 |
17 |
1 |
Inflammation |
Mild, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
7 |
7 |
17 |
1 |
Inflammation |
Minimal, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
11 |
11 |
17 |
1 |
Inflammation |
Mild, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
12 |
12 |
17 |
1 |
Inflammation |
Minimal, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
13 |
13 |
17 |
1 |
Inflammation |
Minimal, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
14 |
14 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
15 |
15 |
17 |
1 |
Inflammation |
Mild, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
16 |
16 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
17 |
17 |
17 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
18 |
18 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
19 |
19 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
20 |
20 |
17 |
1 |
Inflammation |
Mild, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
21 |
21 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
22 |
22 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
23 |
23 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
24 |
24 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
25 |
25 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
26 |
26 |
17 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
27 |
27 |
17 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
28 |
28 |
17 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
29 |
29 |
17 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
30 |
30 |
17 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
12.5 MG/KG |
5 |
8 |
8 |
17 |
1 |
Parakeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
11 |
11 |
17 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
12 |
12 |
17 |
1 |
Parakeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
14 |
14 |
17 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
25 MG/KG |
5 |
15 |
15 |
17 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
16 |
16 |
17 |
1 |
Parakeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
17 |
17 |
17 |
1 |
Parakeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
18 |
18 |
17 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
19 |
19 |
17 |
1 |
Parakeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
50 MG/KG |
5 |
20 |
20 |
17 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
21 |
21 |
17 |
1 |
Parakeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
22 |
22 |
17 |
1 |
Parakeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
23 |
23 |
17 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
24 |
24 |
17 |
1 |
Parakeratosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
100 MG/KG |
5 |
25 |
25 |
17 |
1 |
Parakeratosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
26 |
26 |
17 |
1 |
Parakeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
27 |
27 |
17 |
1 |
Parakeratosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
28 |
28 |
17 |
1 |
Parakeratosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
29 |
29 |
17 |
1 |
Parakeratosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
200 MG/KG |
5 |
30 |
30 |
17 |
1 |
Parakeratosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
12.5 MG/KG |
5 |
6 |
6 |
17 |
1 |
Ulcer |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
25 MG/KG |
5 |
13 |
13 |
17 |
1 |
Ulcer |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
50 MG/KG |
5 |
16 |
16 |
17 |
1 |
Ulcer |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
50 MG/KG |
5 |
17 |
17 |
17 |
1 |
Ulcer |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
50 MG/KG |
5 |
18 |
18 |
17 |
1 |
Ulcer |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
50 MG/KG |
5 |
19 |
19 |
17 |
1 |
Ulcer |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
50 MG/KG |
5 |
20 |
20 |
17 |
1 |
Ulcer |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
100 MG/KG |
5 |
21 |
21 |
17 |
1 |
Ulcer |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
100 MG/KG |
5 |
22 |
22 |
17 |
1 |
Ulcer |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
100 MG/KG |
5 |
23 |
23 |
17 |
1 |
Ulcer |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
100 MG/KG |
5 |
24 |
24 |
17 |
1 |
Ulcer |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
100 MG/KG |
5 |
25 |
25 |
17 |
1 |
Ulcer |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
200 MG/KG |
5 |
26 |
26 |
17 |
1 |
Ulcer |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
200 MG/KG |
5 |
27 |
27 |
17 |
1 |
Ulcer |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
200 MG/KG |
5 |
28 |
28 |
17 |
1 |
Ulcer |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
200 MG/KG |
5 |
29 |
29 |
17 |
1 |
Ulcer |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
200 MG/KG |
5 |
30 |
30 |
17 |
1 |
Ulcer |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
12.5 MG/KG |
5 |
10 |
10 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
12.5 MG/KG |
5 |
6 |
6 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
12.5 MG/KG |
5 |
7 |
7 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
12.5 MG/KG |
5 |
8 |
8 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
12.5 MG/KG |
5 |
9 |
9 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
25 MG/KG |
5 |
11 |
11 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
25 MG/KG |
5 |
12 |
12 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
25 MG/KG |
5 |
13 |
13 |
17 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
25 MG/KG |
5 |
14 |
14 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
25 MG/KG |
5 |
15 |
15 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
50 MG/KG |
5 |
16 |
16 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
50 MG/KG |
5 |
17 |
17 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
50 MG/KG |
5 |
18 |
18 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
50 MG/KG |
5 |
19 |
19 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
50 MG/KG |
5 |
20 |
20 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
100 MG/KG |
5 |
21 |
21 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
100 MG/KG |
5 |
22 |
22 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
100 MG/KG |
5 |
23 |
23 |
17 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
100 MG/KG |
5 |
24 |
24 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
100 MG/KG |
5 |
25 |
25 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
200 MG/KG |
5 |
26 |
26 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
200 MG/KG |
5 |
27 |
27 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
200 MG/KG |
5 |
28 |
28 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
200 MG/KG |
5 |
29 |
29 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Sebaceous Gl |
200 MG/KG |
5 |
30 |
30 |
17 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
|
100 MG/KG |
5 |
23 |
23 |
17 |
1 |
Hemorrhage |
Mild |
Terminal Sacrifice |